BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23898070)

  • 1. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
    Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
    Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
    Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
    Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
    Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cells.
    Kuramitsu Y; Tominaga W; Baron B; Tokuda K; Wang Y; Kitagawa T; Nakamura K
    Anticancer Res; 2013 Jun; 33(6):2557-60. PubMed ID: 23749908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
    Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
    Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.
    Maehara S; Tanaka S; Shimada M; Shirabe K; Saito Y; Takahashi K; Maehara Y
    Int J Cancer; 2004 Nov; 112(2):184-9. PubMed ID: 15352029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
    Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
    Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
    Kang D; Choi HJ; Kang S; Kim SY; Hwang YS; Je S; Han Z; Kim JH; Song JJ
    Cell Signal; 2015 Apr; 27(4):807-17. PubMed ID: 25615626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
    Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
    Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.
    Wei L; Wen JY; Chen J; Ma XK; Wu DH; Chen ZH; Huang JL
    World J Gastroenterol; 2019 Oct; 25(37):5590-5603. PubMed ID: 31602160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
    Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
    Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.